About-cancer / lapaʻau / lāʻau / multi-myeloma
Ua ʻae ʻia nā lāʻau no Multiple Myeloma a me nā Neoplasms Plasma Cell ʻē aʻe
Ua helu ʻia kēia ʻaoʻao i nā lāʻau ʻaila i ʻāpono ʻia e ka Food and Drug Administration (FDA) no myeloma he nui a me nā neoplasms pūnaewele plasma ʻē aʻe. Aia i loko o ka papa inoa nā inoa laulā, nā inoa inoa, a me nā hoʻohuihui lāʻau maʻamau, i hōʻike ʻia i nā hua nui. Loulou nā inoa lāʻau i nā hōʻuluʻulu manaʻo ʻike maʻi maʻi ʻo NCI. Hiki paha i nā lāʻau ke hoʻohana ʻia i nā myeloma he nui a me nā neoplasms cell plasma ʻē aʻe i helu ʻole ʻia ma aneʻi.
Ua ʻae ʻia nā lāʻau no Multiple Myeloma a me nā Neoplasms Plasma Cell ʻē aʻe
Alkeran no ka pahu kui (Melphalan Hydrochloride)
Nā Papa Alkeran (Melphalan)
Aredia (Pamidronate Disodium)
BiCNU (Carmustine)
ʻO Bortezomib
ʻO Carfilzomib
ʻO Carmustine
Cyclophosphamide
ʻO Daratumumab
Darzalex (Daratumumab)
Doxil (Doxorubicin Hydrochloride Liposome)
ʻO Doxorubicin Hydrochloride Liposome
Elotuzumab
Empliciti (Elotuzumab)
Evomela (Melphalan Hydrochloride)
Farydak (Panobinostat)
ʻIxazomib Citrate
Kyprolis (Carfilzomib)
Lenalidomide
Melphalan
Melphalan Hydrochloride
Mozobil (Plerixafor)
Ninlaro (Ixazomib Citrate)
ʻO Pamidronate Disodium
Panobinostat
ʻO Plerixafor
Pomalidomide
Pomalyst (Pomalidomide)
Revlimid (Lenalidomide)
Selinexor
ʻO Thalidomide
Thalomid (Thalidomide)
ʻO Velcade (Bortezomib)
Xpovio (Selinexor)
ʻAla Zoledronic
Zometa (Zoledronic Acid)
Hoʻohui ʻia nā hui hoʻohui lāʻau i Multiple Myeloma a me nā Neoplasms Plasma Cell ʻē aʻe
PAD
